Recombinant Clostridium botulinum Glucose-6-phosphate isomerase (pgi)

Shipped with Ice Packs
In Stock

Description

Biochemical Characteristics

Recombinant C. botulinum pgi is a 50.4 kDa protein with a theoretical pI of 5.45 . Structurally, it forms a 64-kDa homodimer, where each monomer consists of two domains:

  • Large domain: Contains a six-stranded β-sheet and catalytic residues (e.g., His³⁸⁸) .

  • Small domain: Binds phosphate and stabilizes substrate interactions .

The enzyme operates via a three-step mechanism: ring opening, isomerization via an enediol intermediate, and ring closing . Its cytoplasmic role in glycolysis contrasts with extracellular functions, such as immunoglobulin secretion induction and metastasis promotion in cancer cells .

In immunoproteomic studies, pgi was identified as an extracellular immunogenic protein in C. botulinum cultures, suggesting its potential as a diagnostic marker or vaccine candidate . Key findings include:

Spot IDProtein IdentitySubcellular LocationFunction
F7Glucose-6-phosphate isomerase (strain ATCC 3502)CytoplasmicCarbohydrate metabolism
B5Molecular chaperone GroELCytoplasmicProtein folding
F12FlagellinExtracellularMotility and host interaction

pgi’s immunogenicity in C. botulinum highlights its role in host-pathogen interactions, particularly in toxin-producing strains .

Research Applications

  • Metabolic Studies: Used to analyze glycolytic flux in C. botulinum under anaerobic conditions .

  • Biotechnology: Serves as a model for recombinant protein production in clostridial systems .

  • Therapeutic Development: Investigated for antibody production against botulism due to its immunogenic properties .

Challenges and Innovations

  • Stability: Lyophilization with trehalose preserves activity during storage.

  • Yield Optimization: Codon-optimized vectors in E. coli increase expression by 30–50% compared to wild-type constructs .

Future Directions

Ongoing research explores pgi’s role in C. botulinum sporulation and toxin regulation . Additionally, engineered variants with enhanced thermostability (up to 60°C) are being tested for industrial biocatalysis.

Product Specs

Form
Lyophilized powder. We will ship the available format, but please specify any format requirements when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. Proteins are shipped with blue ice packs. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
pgi; CLH_0389Glucose-6-phosphate isomerase; GPI; EC 5.3.1.9; Phosphoglucose isomerase; PGI; Phosphohexose isomerase; PHI
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-449
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Clostridium botulinum (strain Alaska E43 / Type E3)
Target Names
pgi
Target Protein Sequence
MKKGLTLDLS KTQAFVKDYE LDYMEGMVKD SHDRLHSKTG QGNDFLGWID LPVDYDKEEF ARIKKAAEKI QSDSDVLVVI GIGGSYLGAR AAIEMLTSNF HNVLDDNKRK VPKIFYAGNN ISSTYMAELL EAIDGKDVSV NVISKSGTTT EPAIAFRIFK SYLEKKYGVE EARKRIYATT DKSRGALKSL ADAEGYETFV IPDDVGGRFT VLTPVGLLPI AVAGINIDEM MQGAADARES YSNPSLKEND CYKYAVTRNA LYNKGKEIEV LVNYEPCIHY FNEWWKQLYG ESEGKDKKGL FPAAVDFSTD LHSMGQYIQD GRRNLFETVI NVEKARKEIT IEFSEGDLDG LNFLTGKTMD FVNNKAFQGT LLAHNDGEVP NMVLNVPELS PYYFGHMVYF FEKACGISGY LLGINPFDQP GVEAYKKNMF ALLGKPGYED MKDELEKRL
Uniprot No.

Target Background

Function
Catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate.
Database Links

KEGG: cbt:CLH_0389

Protein Families
GPI family
Subcellular Location
Cytoplasm.

Q&A

What is the biochemical function of Glucose-6-phosphate isomerase in Clostridium botulinum metabolism?

Glucose-6-phosphate isomerase, also called phosphoglucose isomerase (PGI) (EC 5.3.1.9), catalyzes the reversible isomerization of glucose-6-phosphate (G-6-P) to fructose-6-phosphate (F-6-P). This enzyme plays a central role in the sugar metabolism of many organisms including Clostridium botulinum . In C. botulinum, PGI functions within a modified Embden-Meyerhof pathway, which is essential for the organism's ability to utilize glucose as an energy source. The enzyme forms part of both glycolytic and gluconeogenic pathways, making it critical for carbon utilization and energy generation, especially under the anaerobic conditions where C. botulinum thrives. Understanding PGI function provides insights into how this pathogen manages energy production in various environments.

How does C. botulinum PGI compare with PGI enzymes from other organisms?

While the search results don't provide direct comparative data for C. botulinum PGI specifically, research on PGI from other organisms offers valuable context. PGIs have been purified and biochemically characterized from various eucarya and bacteria, with crystal structures determined for PGIs from pig, rabbit, and some bacterial species . Notably, some archaeal PGIs (such as from Pyrococcus furiosus) show no significant similarity to the conserved PGI superfamily of eubacteria and eucarya, representing novel types of PGI . This diversity suggests that C. botulinum PGI might have unique structural or functional characteristics that distinguish it from other bacterial PGIs. Comparative analyses would typically involve sequence alignment, structural comparison, and biochemical characterization to determine evolutionary relationships and functional adaptations specific to C. botulinum.

What are the optimal growth conditions for C. botulinum when studying metabolic enzymes like PGI?

C. botulinum is an obligate anaerobe requiring specific culture conditions, particularly when studying metabolic enzymes. Based on established protocols, optimal growth conditions include:

ParameterOptimal ConditionNotes
Temperature30°CCritical for enzymatic activity studies
Duration48-72 hoursAllows for sufficient growth
AtmosphereAnaerobicUsing AnaeroGen (Oxoid) or 10% H₂, 10% CO₂, 80% N₂ atmosphere
Media optionsMT-EYE plates1.5% McClung-Toabe agar, 5% egg yolk extract, 5% yeast extract
TPGY5% tryptone, 0.5% peptone, 0.4% glucose, 2% yeast extract, 0.1% sodium thioglycolate
CMM-TPGYMost effective for sporulation studies

For metabolic studies, researchers should consider that growth medium composition significantly affects enzyme expression levels . When transitioning from initial cultures to experimental work, single colonies should be inoculated into 10 ml of TPGY liquid medium under anaerobic conditions . The biphasic media approach, with solid and liquid phases, has proven particularly effective for C. botulinum cultivation in studies examining metabolic functions .

What genetic manipulation techniques are available for studying the pgi gene in C. botulinum?

Recent advances in C. botulinum genetic manipulation have created powerful tools for studying genes like pgi. The CRISPR-Cas9-based toolkit, particularly the "bookmark" approach, offers precise gene editing capabilities for C. botulinum Group II strains . This methodology involves:

  • Designing single guide RNAs (sgRNAs) targeting the pgi gene

  • Creating a CRISPR-Cas9 vector incorporating homology arms for the targeted region

  • Introducing specific mutations or deletions via homology-directed repair

  • Incorporating a unique 24-nt "bookmark" sequence that can serve as a target for subsequent editing

  • Screening transformants through colony PCR to identify successful mutants

All PCR reactions for these cloning procedures should be performed using high-fidelity DNA polymerases like KOD Hot-Start . For conjugation-based gene transfer into C. botulinum, the established protocol involves:

  • Transforming E. coli CA434 with the appropriate plasmid

  • Washing and mixing with C. botulinum culture

  • Co-incubating on anaerobic TPGY agar for 8-10 hours at 30°C

  • Selecting transformants on appropriate selective media

  • Confirming plasmid curing through replica plating

This genetic toolkit allows for the creation of pgi mutants, complemented strains, and other genetic variants necessary for comprehensive functional studies.

What expression systems are most effective for producing recombinant C. botulinum PGI?

Based on research with similar enzymes, E. coli-based expression systems offer the most practical approach for recombinant C. botulinum PGI production. A successful strategy would involve:

  • Amplifying the pgi gene from C. botulinum genomic DNA using PCR with primers containing appropriate restriction sites

  • Cloning the amplified gene into a suitable expression vector (pBAD-type vectors have been successfully used for similar PGI expressions)

  • Transforming the construct into an appropriate E. coli strain

  • Optimizing expression conditions (temperature, inducer concentration, duration)

When using the pBAD vector system, the recombinant PGI can be expressed under the control of an arabinose-inducible promoter, with expression levels modulated by adjusting arabinose concentration . For proper enzyme folding and activity, consideration should be given to potential requirements for anaerobic expression conditions, as the native enzyme functions in an anaerobic environment.

What methods are available for assessing PGI enzymatic activity in recombinant preparations?

Enzymatic activity of recombinant PGI can be assessed through coupled enzyme assays measuring both forward and reverse reactions:

Forward reaction (G-6-P → F-6-P):

  • Prepare a standard reaction mixture containing:

    • 50 mM Tris-HCl buffer (pH adjusted for assay temperature)

    • Substrate (G-6-P)

    • Coupling enzymes: F-1,6-BP aldolase, TIM, glycerol-phosphate-dehydrogenase

    • 0.5 mM NADH

  • Initiate reaction with purified PGI

  • Monitor NADH oxidation at 365 nm

  • Calculate activity based on the rate of NADH consumption

Reverse reaction (F-6-P → G-6-P):

  • Prepare a reaction mixture containing:

    • 50 mM Tris-HCl buffer

    • Substrate (F-6-P)

  • Preincubate at appropriate temperature

  • Start reaction with PGI sample

  • After specific time intervals, stop the reaction by adding ice-cold stop solution containing:

    • 50 mM Tris-HCl

    • 0.5 mM NADP+

    • Glucose-6-phosphate dehydrogenase (GPDH)

  • Measure NADP+ reduction at 365 nm

  • Calculate reaction rates from the NADP+ reduction values

These assays can be adapted for various reaction conditions to determine optimal pH, temperature, and kinetic parameters.

How can CRISPR-Cas9 technology be applied to study the role of PGI in C. botulinum metabolism and virulence?

CRISPR-Cas9 technology offers powerful approaches for investigating PGI function in C. botulinum:

  • Knockout studies: Creating pgi gene deletions using the CRISPR-Cas9 bookmark approach allows researchers to:

    • Assess the essentiality of PGI for growth on different carbon sources

    • Determine effects on metabolic flux through glycolysis and pentose phosphate pathways

    • Evaluate impacts on sporulation efficiency using established sporulation media like CMM-TPGY

  • Complementation analysis: The watermark approach described for C. botulinum allows for elegant genetic complementation:

    • Restore pgi function with modified genes containing silent mutations

    • Create site-directed mutations in catalytic residues to study structure-function relationships

    • Introduce pgi variants from different strains to assess functional conservation

  • Regulatory studies: CRISPR-Cas9 can be used to modify promoter regions to study:

    • Transcriptional regulation of pgi under different nutritional conditions

    • Connection between carbon metabolism and toxin production

    • Potential metabolic sensing systems affecting pgi expression

For proper experimental design, researchers should employ the biphasic media approach with CMM-TPGY, which has proven effective for C. botulinum studies involving metabolic genes . Comparisons between wild-type, mutant, and complemented strains should include analyses of growth rates, metabolic profiles, and potentially toxin production levels.

What challenges exist in structural studies of C. botulinum PGI and how can they be addressed?

Structural studies of C. botulinum PGI face several challenges that require specific methodological approaches:

  • Protein crystallization challenges:

    • Potential structural flexibility or heterogeneity may complicate crystallization

    • Solution: Screen extensive crystallization conditions, consider co-crystallization with substrates or inhibitors

    • Consider using truncated constructs removing flexible regions identified through limited proteolysis

  • Expression and purification for structural studies:

    • Need for high purity and concentration for crystallography

    • Solution: Multi-step purification approach incorporating:

      • Affinity chromatography (e.g., His-tag purification)

      • Ion exchange chromatography

      • Size exclusion as a final polishing step

  • Structural comparison approaches:

    • In absence of crystal structures, alternative methods include:

    • Homology modeling based on PGI structures from related organisms

    • Hydrogen-deuterium exchange mass spectrometry to map flexible regions

    • Molecular dynamics simulations to understand conformational changes during catalysis

  • Integrating structure with function:

    • Identifying catalytic residues through structure-guided mutagenesis

    • Using the CRISPR-Cas9 system to introduce these mutations in the native organism

    • Correlating structural features with biochemical properties measured using the enzymatic assays described earlier

How does PGI activity correlate with C. botulinum growth phases and sporulation?

This question requires integrated methodology combining enzymatic assays with growth studies. A comprehensive approach would include:

  • Growth phase analysis:

    • Culture C. botulinum in optimal media such as TPGY or CMM-TPGY

    • Sample at defined intervals during lag, exponential, and stationary phases

    • Measure PGI activity using the coupled enzyme assays described earlier

    • Correlate enzymatic activity with growth parameters and glucose utilization rates

  • Sporulation correlation:

    • Utilize the optimized sporulation medium CMM-TPGY identified in previous research

    • Monitor sporulation using phase-contrast microscopy

    • Track PGI activity throughout sporulation process

    • Compare PGI expression and activity between vegetative cells and sporulating cultures

  • Genetic approach:

    • Create conditional pgi mutants using CRISPR-Cas9 technology

    • Assess impacts on sporulation efficiency

    • Determine if PGI activity is required during specific sporulation stages

A typical experimental design would involve:

Growth StageSampling TimeMeasurements
Early exponential6-12hPGI activity, cell density, glucose concentration
Mid-exponential12-24hPGI activity, cell density, glucose concentration
Late exponential24-36hPGI activity, cell density, glucose concentration
Early stationary36-48hPGI activity, cell density, sporulation frequency
Late stationary48-72hPGI activity, cell density, sporulation frequency
Extended incubation1-2 weeksFinal spore counts, residual PGI activity

This integrated approach would reveal connections between central carbon metabolism (represented by PGI) and sporulation processes, which are critical for C. botulinum persistence in various environments.

What are the methodological considerations for comparing PGI activity across different C. botulinum strains?

Comparative analysis of PGI across C. botulinum strains requires standardized methods accounting for strain variations:

  • Strain selection considerations:

    • Include representatives from different phylogenetic groups (Group I-IV)

    • Select strains with different neurotoxin types and subtypes

    • Include both toxigenic and non-toxigenic isolates

    • Consider strains from diverse geographical origins and isolation sources

  • Standardized growth conditions:

    • Use identical media compositions (preferably TPGY or CMM-TPGY)

    • Maintain precise anaerobic conditions (10% H₂, 10% CO₂, 80% N₂)

    • Harvest cells at identical growth phases (mid-exponential recommended)

    • Standardize cell harvesting and lysis protocols

  • Enzyme assay standardization:

    • Use consistent buffer systems and pH values

    • Conduct assays across temperature ranges (25-80°C) to determine strain-specific optima

    • Apply identical protein quantification methods for specific activity calculations

    • Include internal standards to normalize between experimental batches

  • Data analysis approach:

    • Calculate key kinetic parameters (Km, Vmax, kcat, kcat/Km) for each strain

    • Correlate enzymatic properties with phylogenetic relationships

    • Apply statistical methods appropriate for multi-strain comparisons

    • Consider potential correlations with strain-specific virulence or ecological niche

This standardized methodology would reveal strain-specific adaptations in central carbon metabolism and potentially connect metabolic variations to evolutionary relationships identified through core SNP phylogeny analysis .

How can understanding PGI function contribute to food safety interventions targeting C. botulinum?

C. botulinum presents significant food safety challenges due to its spore formation and neurotoxin production. Understanding PGI function could contribute to intervention strategies through:

  • Metabolic inhibition approaches:

    • If PGI is essential for growth or spore germination, specific inhibitors could prevent C. botulinum proliferation

    • Structure-based design of PGI inhibitors would require detailed understanding of the enzyme's active site

    • Testing in food matrices would need to assess inhibitor stability and efficacy under various food processing conditions

  • Biomarker development:

    • PGI activity or abundance could serve as a metabolic biomarker for C. botulinum viability

    • Developing assays detecting PGI activity directly in food matrices might provide rapid detection alternatives

    • Understanding strain variations in PGI could help distinguish between more and less dangerous strains

  • Process intervention targets:

    • Knowledge of how PGI activity relates to spore formation could inform targeted interventions

    • If PGI is needed during sporulation, conditions inhibiting its activity might reduce spore formation

    • Understanding thermal stability of C. botulinum PGI could inform heat treatment regimens

  • Integration with current control strategies:

    • Enhancing existing strategies (pH control, water activity, thermal processing)

    • Developing hurdle approaches combining traditional methods with metabolic inhibition

    • Creating predictive models incorporating PGI activity under various environmental conditions

Food safety researchers should consider that C. botulinum Group II strains in particular pose significant threats to modern packaged foods due to their ability to survive pasteurization and grow at refrigeration temperatures .

What methodological approaches can link PGI function to neurotoxin production in C. botulinum?

Investigating potential connections between central metabolism (PGI function) and neurotoxin production requires sophisticated experimental approaches:

  • Genetic correlation studies:

    • Create precisely defined pgi mutants using CRISPR-Cas9 technology

    • Quantify neurotoxin production in wild-type, mutant, and complemented strains

    • Analyze transcriptional changes in toxin genes when pgi is modified

    • Use the watermark complementation approach to confirm phenotype specificity

  • Metabolic flux analysis:

    • Track carbon flow through glycolysis using isotope-labeled glucose

    • Compare metabolic profiles between toxin-producing and non-producing conditions

    • Identify metabolic branch points potentially regulating toxin production

    • Correlate PGI activity levels with metabolite accumulation patterns

  • Environmental condition correlations:

    • Systematically vary carbon sources and measure both PGI activity and toxin production

    • Test hypotheses about metabolic sensing mechanisms linking these processes

    • Examine potential regulatory factors affecting both metabolism and toxigenesis

  • Proteomics integration:

    • Perform comparative proteomics between wild-type and pgi mutant strains

    • Identify protein interaction networks connecting metabolic enzymes to toxin production

    • Look for post-translational modifications of PGI under different toxin-producing conditions

These methodologies would benefit from the established C. botulinum culturing approaches, particularly the optimized CMM-TPGY medium that supports both growth and sporulation , and could reveal previously unrecognized connections between central metabolism and toxin production.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.